Broncus Technologies, Inc. Release: Over 135 Patients Randomized in Airway Bypass Trial for Emphysema

MOUNTAIN VIEW, CA--(Marketwire - May 19, 2008) - Broncus Technologies, Inc., a medical device company that is investigating a stent-based procedure for the treatment of emphysema, announced today at the Annual Scientific Assembly of the American Thoracic Society (ATS), that over one hundred and thirty-five patients have been randomized in the EASE Trial for airway bypass. The EASE (Exhale Airway Stents for Emphysema) is a randomized, double-blind clinical trial to study the safety and effectiveness of the airway bypass procedure. This study is designed to include up to 450 patients around the world.

MORE ON THIS TOPIC